Positive Phase III For Darolutamide In Prostate Cancer Could Improve Options For Orion

 
• By John Davis
Helsinki
Orion is based in Espoo, close to Finland's capital, Helsinki. • Source: Shutterstock.

More from Clinical Trials

More from R&D